Rani Therapeutics

Price & Volume

Stats

52W Range	$0.38-$3.75
Market Cap	$33.4M
Shares Short	149,332

Financials

Revenue (12 Mos)	$1.2M
Revenue Growth (YoY)	-100%
Gross Profit (12 Mos)	$1.2M
Diluted EPS	-$0.90

News

Yahoo Finance • 3 months ago

Rani Therapeutics stock plunges after $3 million registered direct offering

Yahoo Finance • 3 months ago

Rani Therapeutics announces $3M registered direct offering; shares down nearly 31%

Yahoo Finance • 3 months ago

Rani Therapeutics stock soars after announcing ENDO 2025 presentation

Yahoo Finance • 3 months ago

Rani Therapeutics and ProGen Announce Late Breaking Presentation at ENDO 2025 Demonstrating Bioequivalence of Novel, Bispecific GLP-1/GLP-2 Receptor Agonist Delivered Orally via RaniPill Compared to Subcutaneous Delivery

About

CEO	Mr. Talat Imran
Address	2051 Ringwood Avenue, San Jose, CA, United States, 95131
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	105